Mass transport analysis: Inhalation Rfc methods framework for interspecies dosimetric adjustment

Inhalation Toxicology

Volumn 13, Issue 5, 2001, Pages 437-463

  Hanna, L M ^a   Lou, S R ^a   Su, S ^a   Jarabek, A M ^a  

^a HAI Integrated Risk Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; AIR POLLUTANT; ARTICLE; DOSIMETRY; GAS FLOW; GAS TRANSPORT; LIPID SOLUBILITY; MODEL; PERFUSION; PRIORITY JOURNAL; SOLUBILITY;

EID: 0035000660     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370151126329     Document Type: Article

References (33)

1. Effect of respiratory airflow rate on removal of soluble vapors by the nose
2. Physiologically based clearance/extraction models for vapors metabolized in the nose: An example with methyl methacrylate
3. Understanding mechanisms of inhaled toxicants: Implications for replacing default factors with chemical-specific data
4. A biologically-based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity
5. A CFD-PBPK hybrid model for simulating gas and vapor uptake in the rat nose
6. Incorporation of nasal-lining mass-transfer resistance into a CFD model for prediction of ozone dosimetry in the upper respiratory tract
7. Physiologically based-pharmacokinetic modeling: Principles and applications
8. Respiratory tract suite of models for dosimetric analyses
9. Measurement of local mass transport coefficients in a cast model of the human upper respiratory tract
10. Absorption of soluble gases and vapors in the respiratory system
11. The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches
12. Application requirements for biomarkers in risk assessment
13. Mode of Action: Framework for dosimetry model development
14. Computational fluid dynamics and mass transport calculations update the inhalation reference concentration methods: Rat
15. Sulfure dioxide and exercise: Relationship between response and absorption in upper airways
16. The importance of anatomical realism for validation of physiological models of disposition of inhaled toxicants
17. Computational fluid dynamics and mass transport calculations update the inhalation reference concentration methods: Human
18. Physiological pharmacokinetics: An in vivo approach to membrane transport
19. A model of the regional uptake of gaseous pollutants in the lung. I. The sensitivity of the uptake of ozone in the human lung to lower respiratory tract secretions and to exercise
20. Upper respiratory tract deposition of inspired acetaldehyde
21. A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors
22. Heat and water vapor transfer in the human respiratory system at hyperbaric conditions
23. Dosimetry modeling of inhaled toxic reactive gases
24. A model of the regional uptake of gaseous pollutants in the lung: II. The sensitivity of ozone uptake in laboratory and animal lungs to anatomical and ventilatory parameters
25. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel-tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
26. Commentary: A physiological approach to hepatic drug clearance